PBT loss narrowed 56% on 285% revenue growth, cash fell 59%

On management's preferred frame, total income grew 48% to NZ$71.2m — above the midpoint of upgraded FY24 guidance — so the gap between the canonical revenue line and management's headline points to a presentation/classification difference rather than two views of the same number.

The PBT loss narrowed 56.0% to NZ$15.7m and the NPAT loss narrowed 55.8% to NZ$15.9m, both at the upper edge of the historical range. Operating cash flow swung to a NZ$5.9m inflow from a NZ$18.5m outflow, but capex of NZ$11.4m absorbed all of that and more, so cash on hand fell 59% to NZ$14.1m. Equity dropped 23.3% to NZ$115.7m as accumulated losses ate into reserves.

PBT growth of 56.0% on revenue growth well in excess of cost growth (management cites total spend +1% to NZ$83.9m, below the NZ$86–90m guidance range) shows the scalability case is working at the P&L level. EBITDAF loss collapsed to NZ$1.6m (93% improvement). However, pre-lease free cash flow of -NZ$5.5m is still negative — even though it is within the historical -NZ$42.8m to NZ$3.0m range — and capitalised development of NZ$11.2m remains the dominant cash outflow.

Geographic mix tilted further toward the Booking.com channel. Europe and Other revenue rose to NZ$42.2m, lifting its share of revenue to 61% from 49%. Australia, the legacy enterprise base, grew only modestly to NZ$20.6m and its share fell nearly 9pp. This means the growth engine and the path-to-profit story are increasingly a single-partner channel, which raises the strategic stakes around that relationship.

Cash runway has shortened. Closing cash of NZ$14.1m, down from NZ$34.5m, against a still-negative pre-lease FCF means the FY24 spend underrun was a necessary condition, not an optional one. Debtor days fell to 18.9 from 44.2 (below Annolyse's historical 28.7–92.8 range), which helped the operating cash swing but is also a working-capital benefit that cannot repeat at the same magnitude.

FY24 finished above the middle of upgraded guidance and below the spend range, so the entry point is favourable, but no FY25 EBITDAF or cash target was supplied with this release.

The forward question is whether the operating-leverage trend that took EBITDAF loss to NZ$1.6m converts into positive pre-lease free cash flow at the FY25 income range, given capitalised development is the dominant cash item. Without a stated cash or earnings target, the release supports a directional read on profitability but not a quantified bridge to self-funding.

The effective tax rate of -1.2% is within the historical range and the PBT-to-NPAT growth gap is only 0.2pp, so the loss narrowing is not a tax artefact. Capex intensity dropped sharply to 16.6% of revenue from 90.2%, but absolute capex (NZ$11.4m) still exceeded operating cash, so the FCF improvement is partly a denominator effect from the much larger revenue base.

Two items qualify the read on cash quality. Debtor days at 18.9 are below Annolyse's historical 28.7–92.8 range, contributing a working-capital tailwind that supported operating cash; sustaining 18.9 days as the business scales would be unusual. Second, FY24 spend of NZ$83.9m came in below the NZ$86–90m guidance range, so part of the headline cost discipline reflects timing within the year rather than a structural cost-out, and this is a lever that gets harder to pull again in FY25 against the higher NZ$85–92m income guide.

This briefing cannot assess whether the FY25 income guide is consistent with reaching positive free cash flow, because no FY25 EBITDAF, capex or cash target was disclosed in the supplied release.